Fermentation was carried out in a 50-l first seed fermentor (containing 30 l seed culture) and a 500-l second fermentor (containing 300 l producing medium), successively. The producing medium comprised 1% glucose, 4% soluble amylum, 0.5% yeast extract, 2.5% soybean powder, 0.5% peptone, 0.2% CaCO 3 7 .0. The fermentation was performed at 281C for 7 days stirred at 100 r min À1 with an aeration rate of 30 m 3 of air per hour.
The final 300 l of fermentation broth was filtered to afford the mycelial cake. After it was washed with water, the mycelia was extracted twice with 100 l of EtOH for about 24 h. The EtOH extract was diluted to about 30% EtOH and subjected to a Diaion HP-20 resin column, which was eluted with 30, 40, 50, 60, 70 and 80% EtOH (each concentration eluted 2 bed volumes). The eluents at 70 and 80% EtOH were pooled and concentrated in vacuo at 501C. Then part of the concentrated material (32 g) was chromatographed on a silica gel column, and successively eluted with a stepwise gradient of petroleum ether-acetone (100:0-50:50, v/v) to obtain five fractions (fractions I-V) based on the TLC profiles. Fraction III was chromatographed on another silica gel column and eluted with petroleum ether-acetone (90:10-70:30, v/v) to give three subfractions. Subfraction II was then subjected to a Sephadex LH-20 column (GE Healthcare, Glies, UK) and eluted with EtOH to obtain fractions A and B. Finally, fraction B was fractionated by semi-preparative HPLC with column Zorbax SB-C18 (5 mm, 250Â9.4 mm) on Agilent 1100 system (Agilent, Palo Alto, CA, USA). It was eluted with CH 3 OH-H 2 O (85:15, v/v) at 1.5 ml min À1 . Two main compounds 1 (t R 11.8 min, 8 mg) and 2 (t R 12.7 min, 11 mg) ( Figure 1 ) were isolated.
Compound 1 was obtained as colorless oil with UV (EtOH) l max nm (log e): 211 (4.29), 264 (3.92), 299 (3.52). The absorption peaks in the IR spectrum of 1 suggested the presence of hydroxyl (3447 cm À1 ) and conjugated carbonyl (1656 cm À1 ) groups. Its molecular formula was established as C 17 H 18 O 6 on the basis of HRESIMS, which gave a quasi-molecular ion at m/z 341. (Figure 2) . The downfield proton signal of a hydroxyl at d H 11.65 (7-OH) showed the OH group was in ortho position to the methocarbonyl. In addition to an oxygen atom attachment to C-5 revealed by the 13 C chemical shift of C-5 (d C 162.5), the substituents of tetra-substituted ring A were assigned by the HMBC correlations from H 3 -8 to C-2, C-3, C-4, from d H 11.65 to C-2, C-6, C-7 and from H-6 to C-5. The observed crossing peaks in HMBC spectrum of 1 between d H 3.91 and C-11, d H 5.32 (10-OH) and C-9, C-10, C-11, H 3 -15 and C-12, C-13, C-14, H-12 and C-11, H-14 and C-9 demonstrated the presence of another tetra-substituted benzene ring and established the substituents of ring B as shown in Figure 2 . The ether linkage of the two benzene rings through C-4 and C-9 was confirmed by the molecular formula of C 17 H 18 O 6 . Furthermore, the 1 H and 13 C NMR data of 1 were very similar to those of gerfelin, 8 except the two methoxy groups in 1. This finalized the study and assigned the structure of 1 as methyl 2-hydroxy-4-(2-hydroxy-3-methoxy-5-methylphenoxy)-6-methylbenzoate.
Compound 2 was also isolated as colorless oil with UV (EtOH) l max nm (log e): 217 (4.50), 264 (4.12), 302 (3.72). The IR spectrum of 2 showed the presence of hydroxyl (3447 cm À1 ) and conjugated carbonyl (1655 cm À1 ) groups. The 1 H NMR spectrum of 2 indicated five aromatic protons, two aromatic methyls, a downfield OH signal and a methoxy group. In the 13 C NMR spectrum of 2, there were 12 sp 2 carbons in addition to three methyl carbons (one oxygenated one) and one carbonyl. These suggested the presence of two benzene rings in 2. Comparison of the NMR data (Table 1) of 2 with those of cordyol B, 9 showed that compound 2 was identical to the aglycone of cordyol B and elucidated the structure of 2 as methyl 2-hydroxy-4-(3-hydroxy-5-methylphenoxy)-6-methylbenzoate.
We examined the inhibitory activity of compounds 1 and 2 against the growth of human lung adenocarcinoma cell line A549 using the CCK-8 colorimetric method as described in our preceding paper. 10 The result showed that compounds 1 and 2 inhibited the growth of A549 cells dose-dependently with an IC 50 value of 5.3 and 15.2 mg ml À1 , respectively. Figure 2 Key HMBC correlations of 1.
